Medesis Pharma S.A. (ALMDP.PA)
EUR 0.35
(0.0%)
EUR 0.35
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 164.62 Thousand EUR | 26.05% |
| 2022 | 130.59 Thousand EUR | 30.27% |
| 2021 | 100.24 Thousand EUR | 80.16% |
| 2020 | 55.64 Thousand EUR | 114.02% |
| 2019 | 26 Thousand EUR | 52.94% |
| 2018 | 17 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 157.19 Thousand EUR | 0.0% |
| 2023 FY | 164.62 Thousand EUR | 26.05% |
| 2023 Q4 | 164.62 Thousand EUR | 0.0% |
| 2023 Q3 | 164.62 Thousand EUR | 4.73% |
| 2023 Q1 | 157.19 Thousand EUR | 20.36% |
| 2022 Q4 | 130.59 Thousand EUR | 0.0% |
| 2022 Q3 | 130.59 Thousand EUR | 34.11% |
| 2022 FY | 130.59 Thousand EUR | 30.27% |
| 2022 Q2 | 97.38 Thousand EUR | 0.0% |
| 2022 Q1 | 97.38 Thousand EUR | -2.86% |
| 2021 Q3 | 100.24 Thousand EUR | -25.77% |
| 2021 Q2 | 135.05 Thousand EUR | 0.0% |
| 2021 Q1 | 135.05 Thousand EUR | 142.72% |
| 2021 Q4 | 100.24 Thousand EUR | 0.0% |
| 2021 FY | 100.24 Thousand EUR | 80.16% |
| 2020 Q2 | 48 Thousand EUR | 0.0% |
| 2020 FY | 55.64 Thousand EUR | 114.02% |
| 2020 Q4 | 55.64 Thousand EUR | 0.0% |
| 2020 Q3 | 55.64 Thousand EUR | 15.93% |
| 2019 FY | 26 Thousand EUR | 52.94% |
| 2018 FY | 17 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 25.51% |
| ABIVAX Société Anonyme | 1.00 EUR | -16462100.0% |
| Adocia SA | 272 Thousand EUR | 39.477% |
| Aelis Farma SA | 53 Thousand EUR | -210.608% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 90.544% |
| genOway Société anonyme | 982.75 Thousand EUR | 83.249% |
| IntegraGen SA | 311.44 Thousand EUR | 47.143% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 114.849% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 86.557% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 238.134% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -80.903% |
| Valbiotis SA | 1 Million EUR | 83.62% |
| TheraVet SA | 123.34 Thousand EUR | -33.468% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -16462100.0% |
| DBV Technologies S.A. | 1.00 USD | -16462100.0% |
| Genfit S.A. | 4000.00 EUR | -4015.55% |
| GeNeuro SA | - EUR | -Infinity% |
| Innate Pharma S.A. | 1.00 EUR | -16462100.0% |
| Inventiva S.A. | 417 Thousand EUR | 60.522% |
| MaaT Pharma SA | 190 Thousand EUR | 13.357% |
| MedinCell S.A. | -6.71 Million EUR | 102.452% |
| Nanobiotix S.A. | 200 Thousand EUR | 17.689% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Poxel S.A. | 2.95 Million EUR | 94.431% |
| GenSight Biologics S.A. | 1.00 EUR | -16462100.0% |
| Transgene SA | - EUR | -Infinity% |
| Valneva SE | 44.46 Million EUR | 99.63% |